Literature DB >> 24335130

Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis.

P J Vlaar1, M van Hulst, C A Benne, W M Janssen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24335130      PMCID： PMC3862103          DOI： 10.3747/pdi.2012.00155

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  3 in total

1.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Intraperitoneal meropenem administration: a possible alternative to the intravenous route.

Authors:  C Van Ende; M Tintillier; C Cuvelier; G Migali; J M Pochet
Journal:  Perit Dial Int       Date:  2010 Mar-Apr       Impact factor: 1.756

Review 3.  Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.

Authors:  F Thalhammer; W H Hörl
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447
  3 in total
  6 in total

1.  An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.

Authors:  Martin Wiesholzer; Petra Pichler; Gottfried Reznicek; Michaela Wimmer; Manuel Kussmann; Peter Balcke; Heinz Burgmann; Markus Zeitlinger; Wolfgang Poeppl
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  Intraperitoneal Meropenem for Polymicrobial Peritoneal Dialysis-Related Peritonitis.

Authors:  Caroline W H de Fijter; Lily Jakulj; Fariba Amiri; Anthe Zandvliet; Eric Franssen
Journal:  Perit Dial Int       Date:  2016 9-10       Impact factor: 1.756

3.  Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.

Authors:  Manuel Kussmann; Linda Schuster; Sarah Wrenger; Petra Pichler; Gottfried Reznicek; Heinz Burgmann; Wolfgang Poeppl; Markus Zeitlinger; Martin Wiesholzer
Journal:  Perit Dial Int       Date:  2016-09-28       Impact factor: 1.756

4.  Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: Antimicrobial Susceptibility Profiles of a Referral Center in GERMANY over 32 Years.

Authors:  Daniel Kitterer; Joerg Latus; Christoph Pöhlmann; M Dominik Alscher; Martin Kimmel
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

5.  Intraperitoneal meropenem for peritoneal dialysis peritonitis with Serratia marcescens immediately on commencing dialysis.

Authors:  P Bhave; P Tregaskis; R Walker; S Wilson
Journal:  New Microbes New Infect       Date:  2016-01-27

Review 6.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.